Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Currax Pharmaceuticals
Currax Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Onzetra
Sumatriptan
2016-01-27
2024-2036
Migraine disorders
,
Cluster headache
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
Silenor
Doxepin
2010-03-17
2027-2030
Atopic dermatitis
,
Pruritus
,
Pain
,
Anxiety disorders
,
Psychotic affective disorders
,
Depressive disorder
Treximet
Naproxen
,
Sumatriptan
2008-04-15
2025-2026
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
,
Gastroesophageal reflux
,
Helicobacter infections
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Nausea
,
Sleep initiation and maintenance disorders
,
Allergic rhinitis perennial
,
Urticaria
,
Motion sickness
,
Sneezing
,
Anxiety disorders
,
Sinusitis
,
Asthma
,
Stomach ulcer
,
Migraine disorders
,
Cluster headache
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Naproxen
knee osteoarthritis
,
hip osteoarthritis
,
osteoarthritis
,
menorrhagia
Sumatriptan
healthy volunteers/patients
Doxepin
ataxia
,
healthy volunteers/patients
Benzocaine
psoriasis
,
hypertriglyceridemia
,
pancreatic neoplasms
Lorcaserin
obesity
Arm1
neuralgia
,
hyperalgesia
,
penile induration
,
retinal vein occlusion
,
macular edema
,
macular degeneration
,
edema
,
papilledema
,
epiretinal membrane
,
stroke
,
muscle spasticity
Prudoxin
parkinson disease
,
carcinoma
,
breast neoplasms
,
dermatitis
,
radiodermatitis
,
neoplasms
,
non-small-cell lung carcinoma
,
thyroid neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
sarcoma
,
lymphoma
,
second primary neoplasms
,
small cell lung carcinoma
,
thymoma
,
mesothelioma
,
thymus neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
irritable bowel syndrome
,
syndrome
,
psychophysiologic disorders
,
somatoform disorders
,
stomatitis
,
mucositis
,
dementia
,
schizophrenia
,
anxiety disorders
,
head and neck neoplasms
,
pain
,
urticaria
,
pruritus
,
sleep initiation and maintenance disorders
,
depression
,
atrophy
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
hiv infections
,
ataxia
,
healthy volunteers/patients
,
drug-related side effects and adverse reactions
,
drug interactions
,
bipolar disorder
,
gastrointestinal diseases
,
dyspepsia
,
digestive system diseases
,
nasopharyngeal carcinoma
,
breakthrough pain
Wellbutrin
type 2 diabetes mellitus
,
hiv infections
,
seasonal affective disorder
,
bipolar disorder
,
psychological sexual dysfunctions
,
crohn disease
,
epilepsy
,
lethargy
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
mood disorders
,
depressive disorder
,
major depressive disorder
,
depression
,
smoking cessation
,
mental disorders
,
problem behavior
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
breast neoplasms
,
dysthymic disorder
,
tobacco use disorder
,
cardiovascular diseases
,
myocardial infarction
,
unstable angina
,
infarction
,
smoking
,
congenital abnormalities
,
pregnancy
,
neoplasms
Apd356
obesity
Arm2
neuralgia
,
hyperalgesia
,
penile induration
,
macular edema
,
retinal vein occlusion
,
stroke
,
muscle spasticity
Belviq
obesity
Mydfrin
healthy volunteers/patients
,
pharmacokinetics
,
biological availability
,
type 1 diabetes mellitus
,
type 2 diabetes mellitus
,
diabetes mellitus
,
hyperglycemia
,
cardiovascular diseases
,
drug-related side effects and adverse reactions
,
alzheimer disease
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
heart failure
,
therapeutic equivalency
,
hypertriglyceridemia
,
gastroesophageal reflux
,
peptic esophagitis
,
asthma
,
barrett esophagus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use